Tenax Therapeutics, Inc. (TENX) NASDAQ

5.85

-0.045(-0.76%)

Updated at July 16 04:00PM

Currency In USD

Valuation

Market Cap94.53M
Enterprise Value-319,147
P/E Ratio-8.87
PEG Ratio-0.2
Price/Sales Ratio0
Price/Book Ratio1.96
Enterprise/Revenue0
Enterprise/EBITDA6.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.22
Return On Equity-0.32

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-17.58M
Net Income-17.6M
Diluted EPS-1.15

Balance Sheet

Total Cash111.45M
Total Cash/Share3.05
Total Debt0
Total Debt/Equity0
Current Ratio40.48
Book Value Per Share2.99

Price History

52-Week Change71.14
52-Week High7.89
52-Week Low2.8
Moving Average 50 Days5.83
Moving Average 200 Days5.62

Statistics

Average Volume22,330
Shares Outstanding4.15M
% Held by Institutions5.48

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:80
Last Split DateJanuary 03, 2024